Industry Research Reports

Home > Reports > Medical Care > Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

Industry: Medical Care

Published Date: 2026-03-09

Pages: 106 Pages

Report ld: 6062495

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Cell Therapy Regenerative Medicine Market Size(US$)

CAGR 2026-2032

17.3%

Market Size,2032

USD 81,560

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 31,380 million

Market Forecast in 2032(Value)

US$ 81,560 million

CAGR

17.3%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Cell Therapy Regenerative Medicine market size was US$ 27160 million in 2025 and is forecast to reach a readjusted size of US$ 81560 million by 2032 with a CAGR of 17.3% during the forecast period 2026-2032.

The global cell therapy and regenerative medicine market is expected to reach $23.5 billion in 2024, with a gross profit margin of approximately 50-70%.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

The upstream process involves cell preparation, consisting of "chips, consumables, and reagents." Equipment includes physical safety cabinets, isolators, closed automated bioreactors, programmed cooling units, and liquid nitrogen tanks. Consumables include cell culture bags, sterile pipettes/thermostats, and cryotubes. Reagents include serum-free culture media, cytokines, activating antibodies, and magnetic beads.

Future advancements in cell therapy will depend heavily on deep integration with other cutting-edge technologies.

Gene editing technology: Gene editing tools, such as CRISPR, are advancing cell therapy from simple cell replacement to therapies capable of precisely repairing disease-causing genes. For example, the base editing therapy BEAM-101, which has received orphan drug designation, aims to activate fetal hemoglobin by editing a specific gene to treat blood disorders such as beta-thalassemia. This represents a more precise and safer path to gene correction.

Artificial Intelligence and Automation: The complex, personalized manufacturing processes of cell therapies are key constraints to their accessibility. AI and automation technologies are addressing this bottleneck. For example, companies are collaborating to develop AI-driven automated cell therapy platforms to achieve standardized, scalable production. Meanwhile, instrument-free, large-scale cell sorting technologies have emerged, significantly reducing time and costs.

Exploring new cell models: Beyond technology platforms, research into cells themselves is also deepening. For example, patient-derived organoids are being used for more precise drug screening, while microbubble-based cell sorting platforms are enabling more efficient production processes.

The global Cell Therapy Regenerative Medicine market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.

MARKET SEGMENTATION

By Company

DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Allergan
MiMedx Group
Organogenesis
UniQure
FUJIFILM Cellular Dynamics
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
MD Anderson

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Stem Cell Therapy
Tissue Engineering and 3D Bioprinting
Immune Cell Therapy
Gene-Edited Cell Therapy

Segment by Application

Hospital
Medical Research Center
Others

Segment by Category

Autologous
Allogeneic
Xenogeneic

Segment by Division

Live Cell Therapy
Cell-Free Exosome/Secretome Therapy

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Cell Therapy Regenerative Medicine value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032

1.2.2 Stem Cell Therapy

1.2.3 Tissue Engineering and 3D Bioprinting

1.2.4 Immune Cell Therapy

1.2.5 Gene-Edited Cell Therapy

1.3 Market by Application

1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Medical Research Center

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Therapy Regenerative Medicine Market Perspective (2021-2032)

2.2 Global Market Size by Region: 2021 vs 2025 vs 2032

2.3 Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Region (2021-2026)

2.4 Global Cell Therapy Regenerative Medicine Revenue Forecast by Region (2027-2032)

2.5 Major Regions and Emerging Markets Analysis

2.5.1 North America Cell Therapy Regenerative Medicine Market Size and Prospective (2021-2032)

2.5.2 Europe Cell Therapy Regenerative Medicine Market Size and Prospective (2021-2032)

2.5.3 China Cell Therapy Regenerative Medicine Market Size and Prospective (2021-2032)

2.5.4 Japan Cell Therapy Regenerative Medicine Market Size and Prospective (2021-2032)

3 Breakdown Data by Type

3.1 Global Cell Therapy Regenerative Medicine Historical Market Size by Type (2021-2026)

3.2 Global Cell Therapy Regenerative Medicine Forecasted Market Size by Type (2027-2032)

3.3 Representative Players for Different Types of Cell Therapy Regenerative Medicine

4 Breakdown Data by Application

4.1 Global Cell Therapy Regenerative Medicine Historical Market Size by Application (2021-2026)

4.2 Global Cell Therapy Regenerative Medicine Forecasted Market Size by Application (2027-2032)

4.3 New Sources of Growth in Cell Therapy Regenerative Medicine Applications

5 Competitive Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Cell Therapy Regenerative Medicine Players by Revenue (2021-2026)

5.1.2 Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Players (2021-2026)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Cell Therapy Regenerative Medicine Revenue

5.4 Global Cell Therapy Regenerative Medicine Market Concentration Analysis

5.4.1 Global Cell Therapy Regenerative Medicine Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Cell Therapy Regenerative Medicine Revenue in 2025

5.5 Global Key Players of Cell Therapy Regenerative Medicine Head Offices and Areas Served

5.6 Global Key Players of Cell Therapy Regenerative Medicine, Product and Application

5.7 Global Key Players of Cell Therapy Regenerative Medicine, Date of Entry into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Cell Therapy Regenerative Medicine Revenue by Company (2021-2026)

6.1.2 North America Market Size by Type

6.1.2.1 North America Cell Therapy Regenerative Medicine Market Size by Type (2021-2026)

6.1.2.2 North America Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

6.1.3 North America Market Size by Application

6.1.3.1 North America Cell Therapy Regenerative Medicine Market Size by Application (2021-2026)

6.1.3.2 North America Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

6.1.4 North America Cell Therapy Regenerative Medicine Major Customers

6.1.5 North America Market Trends and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Cell Therapy Regenerative Medicine Revenue by Company (2021-2026)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Cell Therapy Regenerative Medicine Market Size by Type (2021-2026)

6.2.2.2 Europe Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Cell Therapy Regenerative Medicine Market Size by Application (2021-2026)

6.2.3.2 Europe Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

6.2.4 Europe Cell Therapy Regenerative Medicine Major Customers

6.2.5 Europe Market Trends and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Cell Therapy Regenerative Medicine Revenue by Company (2021-2026)

6.3.2 China Market Size by Type

6.3.2.1 China Cell Therapy Regenerative Medicine Market Size by Type (2021-2026)

6.3.2.2 China Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

6.3.3 China Market Size by Application

6.3.3.1 China Cell Therapy Regenerative Medicine Market Size by Application (2021-2026)

6.3.3.2 China Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

6.3.4 China Cell Therapy Regenerative Medicine Major Customers

6.3.5 China Market Trends and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Cell Therapy Regenerative Medicine Revenue by Company (2021-2026)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Cell Therapy Regenerative Medicine Market Size by Type (2021-2026)

6.4.2.2 Japan Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Cell Therapy Regenerative Medicine Market Size by Application (2021-2026)

6.4.3.2 Japan Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

6.4.4 Japan Cell Therapy Regenerative Medicine Major Customers

6.4.5 Japan Market Trends and Opportunities

7 Key Player Profiles

7.1 DePuy Synthes

7.1.1 DePuy Synthes Company Details

7.1.2 DePuy Synthes Business Overview

7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Introduction

7.1.4 DePuy Synthes Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.1.5 DePuy Synthes Recent Development

7.2 Medtronic

7.2.1 Medtronic Company Details

7.2.2 Medtronic Business Overview

7.2.3 Medtronic Cell Therapy Regenerative Medicine Introduction

7.2.4 Medtronic Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.2.5 Medtronic Recent Development

7.3 ZimmerBiomet

7.3.1 ZimmerBiomet Company Details

7.3.2 ZimmerBiomet Business Overview

7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Introduction

7.3.4 ZimmerBiomet Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.3.5 ZimmerBiomet Recent Development

7.4 Stryker

7.4.1 Stryker Company Details

7.4.2 Stryker Business Overview

7.4.3 Stryker Cell Therapy Regenerative Medicine Introduction

7.4.4 Stryker Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.4.5 Stryker Recent Development

7.5 Allergan

7.5.1 Allergan Company Details

7.5.2 Allergan Business Overview

7.5.3 Allergan Cell Therapy Regenerative Medicine Introduction

7.5.4 Allergan Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.5.5 Allergan Recent Development

7.6 MiMedx Group

7.6.1 MiMedx Group Company Details

7.6.2 MiMedx Group Business Overview

7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Introduction

7.6.4 MiMedx Group Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.6.5 MiMedx Group Recent Development

7.7 Organogenesis

7.7.1 Organogenesis Company Details

7.7.2 Organogenesis Business Overview

7.7.3 Organogenesis Cell Therapy Regenerative Medicine Introduction

7.7.4 Organogenesis Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.7.5 Organogenesis Recent Development

7.8 UniQure

7.8.1 UniQure Company Details

7.8.2 UniQure Business Overview

7.8.3 UniQure Cell Therapy Regenerative Medicine Introduction

7.8.4 UniQure Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.8.5 UniQure Recent Development

7.9 FUJIFILM Cellular Dynamics

7.9.1 FUJIFILM Cellular Dynamics Company Details

7.9.2 FUJIFILM Cellular Dynamics Business Overview

7.9.3 FUJIFILM Cellular Dynamics Cell Therapy Regenerative Medicine Introduction

7.9.4 FUJIFILM Cellular Dynamics Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.9.5 FUJIFILM Cellular Dynamics Recent Development

7.10 Osiris Therapeutics

7.10.1 Osiris Therapeutics Company Details

7.10.2 Osiris Therapeutics Business Overview

7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Introduction

7.10.4 Osiris Therapeutics Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.10.5 Osiris Therapeutics Recent Development

7.11 Vcanbio

7.11.1 Vcanbio Company Details

7.11.2 Vcanbio Business Overview

7.11.3 Vcanbio Cell Therapy Regenerative Medicine Introduction

7.11.4 Vcanbio Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.11.5 Vcanbio Recent Development

7.12 Gamida Cell

7.12.1 Gamida Cell Company Details

7.12.2 Gamida Cell Business Overview

7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Introduction

7.12.4 Gamida Cell Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.12.5 Gamida Cell Recent Development

7.13 Golden Meditech

7.13.1 Golden Meditech Company Details

7.13.2 Golden Meditech Business Overview

7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Introduction

7.13.4 Golden Meditech Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.13.5 Golden Meditech Recent Development

7.14 Cytori

7.14.1 Cytori Company Details

7.14.2 Cytori Business Overview

7.14.3 Cytori Cell Therapy Regenerative Medicine Introduction

7.14.4 Cytori Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.14.5 Cytori Recent Development

7.15 Celgene

7.15.1 Celgene Company Details

7.15.2 Celgene Business Overview

7.15.3 Celgene Cell Therapy Regenerative Medicine Introduction

7.15.4 Celgene Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.15.5 Celgene Recent Development

7.16 Vericel Corporation

7.16.1 Vericel Corporation Company Details

7.16.2 Vericel Corporation Business Overview

7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Introduction

7.16.4 Vericel Corporation Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.16.5 Vericel Corporation Recent Development

7.17 Guanhao Biotech

7.17.1 Guanhao Biotech Company Details

7.17.2 Guanhao Biotech Business Overview

7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Introduction

7.17.4 Guanhao Biotech Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.17.5 Guanhao Biotech Recent Development

7.18 Mesoblast

7.18.1 Mesoblast Company Details

7.18.2 Mesoblast Business Overview

7.18.3 Mesoblast Cell Therapy Regenerative Medicine Introduction

7.18.4 Mesoblast Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.18.5 Mesoblast Recent Development

7.19 Stemcell Technologies

7.19.1 Stemcell Technologies Company Details

7.19.2 Stemcell Technologies Business Overview

7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Introduction

7.19.4 Stemcell Technologies Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.19.5 Stemcell Technologies Recent Development

7.20 MD Anderson

7.20.1 MD Anderson Company Details

7.20.2 MD Anderson Business Overview

7.20.3 MD Anderson Cell Therapy Regenerative Medicine Introduction

7.20.4 MD Anderson Revenue in Cell Therapy Regenerative Medicine Business (2021-2026)

7.20.5 MD Anderson Recent Development

8 Cell Therapy Regenerative Medicine Market Dynamics

8.1 Cell Therapy Regenerative Medicine Industry Trends

8.2 Cell Therapy Regenerative Medicine Market Drivers

8.3 Cell Therapy Regenerative Medicine Market Challenges

8.4 Cell Therapy Regenerative Medicine Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Cell Therapy Regenerative Medicine Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Global Cell Therapy Regenerative Medicine Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 3. Global Market Cell Therapy Regenerative Medicine Market Size (US$ Million) by Region:2021 vs 2025 vs 2032

Table 4. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) Market Share by Region (2021-2026)

Table 5. Global Cell Therapy Regenerative Medicine Revenue Share by Region (2021-2026)

Table 6. Global Cell Therapy Regenerative Medicine Revenue (US$ Million) Forecast by Region (2027-2032)

Table 7. Global Cell Therapy Regenerative Medicine Revenue Share Forecast by Region (2027-2032)

Table 8. Global Cell Therapy Regenerative Medicine Market Size by Type (2021-2026) & (US$ Million)

Table 9. Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Type (2021-2026)

Table 10. Global Cell Therapy Regenerative Medicine Forecasted Market Size by Type (2027-2032) & (US$ Million)

Table 11. Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Type (2027-2032)

Table 12. Representative Players of Each Type

Table 13. Global Cell Therapy Regenerative Medicine Market Size by Application (2021-2026) & (US$ Million)

Table 14. Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Application (2021-2026)

Table 15. Global Cell Therapy Regenerative Medicine Forecasted Market Size by Application (2027-2032) & (US$ Million)

Table 16. Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Application (2027-2032)

Table 17. New Sources of Growth in Cell Therapy Regenerative Medicine Applications

Table 18. Global Cell Therapy Regenerative Medicine Revenue by Players (2021-2026) & (US$ Million)

Table 19. Global Cell Therapy Regenerative Medicine Market Share by Players (2021-2026)

Table 20. Global Top Cell Therapy Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Regenerative Medicine as of 2025)

Table 21. Ranking of Global Top Cell Therapy Regenerative Medicine Companies by Revenue (US$ Million) in 2025

Table 22. Global 5 Largest Players Market Share by Cell Therapy Regenerative Medicine Revenue (CR5 and HHI) & (2021-2026)

Table 23. Global Key Players of Cell Therapy Regenerative Medicine, Headquarters and Area Served

Table 24. Global Key Players of Cell Therapy Regenerative Medicine, Product and Application

Table 25. Global Key Players of Cell Therapy Regenerative Medicine, Date of Entry into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Cell Therapy Regenerative Medicine Revenue by Company (2021-2026) & (US$ Million)

Table 28. North America Cell Therapy Regenerative Medicine Market Share by Revenue, by Company (2021-2026)

Table 29. North America Cell Therapy Regenerative Medicine Market Size by Type (2021-2026) & (US$ Million)

Table 30. North America Cell Therapy Regenerative Medicine Market Size by Application (2021-2026) & (US$ Million)

Table 31. Europe Cell Therapy Regenerative Medicine Revenue by Company (2021-2026) & (US$ Million)

Table 32. Europe Cell Therapy Regenerative Medicine Market Share by Revenue, by Company (2021-2026)

Table 33. Europe Cell Therapy Regenerative Medicine Market Size by Type (2021-2026) & (US$ Million)

Table 34. Europe Cell Therapy Regenerative Medicine Market Size by Application (2021-2026) & (US$ Million)

Table 35. China Cell Therapy Regenerative Medicine Revenue by Company (2021-2026) & (US$ Million)

Table 36. China Cell Therapy Regenerative Medicine Market Share by Revenue, by Company (2021-2026)

Table 37. China Cell Therapy Regenerative Medicine Market Size by Type (2021-2026) & (US$ Million)

Table 38. China Cell Therapy Regenerative Medicine Market Size by Application (2021-2026) & (US$ Million)

Table 39. Japan Cell Therapy Regenerative Medicine Revenue by Company (2021-2026) & (US$ Million)

Table 40. Japan Cell Therapy Regenerative Medicine Market Share by Revenue, by Company (2021-2026)

Table 41. Japan Cell Therapy Regenerative Medicine Market Size by Type (2021-2026) & (US$ Million)

Table 42. Japan Cell Therapy Regenerative Medicine Market Size by Application (2021-2026) & (US$ Million)

Table 43. DePuy Synthes Company Details

Table 44. DePuy Synthes Business Overview

Table 45. DePuy Synthes Cell Therapy Regenerative Medicine Product

Table 46. DePuy Synthes Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 47. DePuy Synthes Recent Development

Table 48. Medtronic Company Details

Table 49. Medtronic Business Overview

Table 50. Medtronic Cell Therapy Regenerative Medicine Product

Table 51. Medtronic Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 52. Medtronic Recent Development

Table 53. ZimmerBiomet Company Details

Table 54. ZimmerBiomet Business Overview

Table 55. ZimmerBiomet Cell Therapy Regenerative Medicine Product

Table 56. ZimmerBiomet Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 57. ZimmerBiomet Recent Development

Table 58. Stryker Company Details

Table 59. Stryker Business Overview

Table 60. Stryker Cell Therapy Regenerative Medicine Product

Table 61. Stryker Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 62. Stryker Recent Development

Table 63. Allergan Company Details

Table 64. Allergan Business Overview

Table 65. Allergan Cell Therapy Regenerative Medicine Product

Table 66. Allergan Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 67. Allergan Recent Development

Table 68. MiMedx Group Company Details

Table 69. MiMedx Group Business Overview

Table 70. MiMedx Group Cell Therapy Regenerative Medicine Product

Table 71. MiMedx Group Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 72. MiMedx Group Recent Development

Table 73. Organogenesis Company Details

Table 74. Organogenesis Business Overview

Table 75. Organogenesis Cell Therapy Regenerative Medicine Product

Table 76. Organogenesis Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 77. Organogenesis Recent Development

Table 78. UniQure Company Details

Table 79. UniQure Business Overview

Table 80. UniQure Cell Therapy Regenerative Medicine Product

Table 81. UniQure Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 82. UniQure Recent Development

Table 83. FUJIFILM Cellular Dynamics Company Details

Table 84. FUJIFILM Cellular Dynamics Business Overview

Table 85. FUJIFILM Cellular Dynamics Cell Therapy Regenerative Medicine Product

Table 86. FUJIFILM Cellular Dynamics Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 87. FUJIFILM Cellular Dynamics Recent Development

Table 88. Osiris Therapeutics Company Details

Table 89. Osiris Therapeutics Business Overview

Table 90. Osiris Therapeutics Cell Therapy Regenerative Medicine Product

Table 91. Osiris Therapeutics Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 92. Osiris Therapeutics Recent Development

Table 93. Vcanbio Company Details

Table 94. Vcanbio Business Overview

Table 95. Vcanbio Cell Therapy Regenerative Medicine Product

Table 96. Vcanbio Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 97. Vcanbio Recent Development

Table 98. Gamida Cell Company Details

Table 99. Gamida Cell Business Overview

Table 100. Gamida Cell Cell Therapy Regenerative Medicine Product

Table 101. Gamida Cell Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 102. Gamida Cell Recent Development

Table 103. Golden Meditech Company Details

Table 104. Golden Meditech Business Overview

Table 105. Golden Meditech Cell Therapy Regenerative Medicine Product

Table 106. Golden Meditech Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 107. Golden Meditech Recent Development

Table 108. Cytori Company Details

Table 109. Cytori Business Overview

Table 110. Cytori Cell Therapy Regenerative Medicine Product

Table 111. Cytori Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 112. Cytori Recent Development

Table 113. Celgene Company Details

Table 114. Celgene Business Overview

Table 115. Celgene Cell Therapy Regenerative Medicine Product

Table 116. Celgene Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 117. Celgene Recent Development

Table 118. Vericel Corporation Company Details

Table 119. Vericel Corporation Business Overview

Table 120. Vericel Corporation Cell Therapy Regenerative Medicine Product

Table 121. Vericel Corporation Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 122. Vericel Corporation Recent Development

Table 123. Guanhao Biotech Company Details

Table 124. Guanhao Biotech Business Overview

Table 125. Guanhao Biotech Cell Therapy Regenerative Medicine Product

Table 126. Guanhao Biotech Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 127. Guanhao Biotech Recent Development

Table 128. Mesoblast Company Details

Table 129. Mesoblast Business Overview

Table 130. Mesoblast Cell Therapy Regenerative Medicine Product

Table 131. Mesoblast Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 132. Mesoblast Recent Development

Table 133. Stemcell Technologies Company Details

Table 134. Stemcell Technologies Business Overview

Table 135. Stemcell Technologies Cell Therapy Regenerative Medicine Product

Table 136. Stemcell Technologies Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 137. Stemcell Technologies Recent Development

Table 138. MD Anderson Company Details

Table 139. MD Anderson Business Overview

Table 140. MD Anderson Cell Therapy Regenerative Medicine Product

Table 141. MD Anderson Revenue in Cell Therapy Regenerative Medicine Business (2021-2026) & (US$ Million)

Table 142. MD Anderson Recent Development

Table 143. Cell Therapy Regenerative Medicine Market Trends

Table 144. Cell Therapy Regenerative Medicine Market Drivers

Table 145. Cell Therapy Regenerative Medicine Market Challenges

Table 146. Cell Therapy Regenerative Medicine Market Restraints

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Cell Therapy Regenerative Medicine Product Picture

Figure 2. Global Cell Therapy Regenerative Medicine Market Share by Type: 2025 vs 2032

Figure 3. Stem Cell Therapy Features

Figure 4. Tissue Engineering and 3D Bioprinting Features

Figure 5. Immune Cell Therapy Features

Figure 6. Gene-Edited Cell Therapy Features

Figure 7. Global Cell Therapy Regenerative Medicine Market Share by Application: 2025 vs 2032

Figure 8. Hospital

Figure 9. Medical Research Center

Figure 10. Others

Figure 11. Cell Therapy Regenerative Medicine Report Years Considered

Figure 12. Global Cell Therapy Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2021-2032

Figure 13. Global Cell Therapy Regenerative Medicine Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Cell Therapy Regenerative Medicine Market Share by Revenue, by Region: 2021 vs 2025

Figure 15. North America Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2021-2032)

Figure 16. Europe Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2021-2032)

Figure 17. China Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2021-2032)

Figure 18. Japan Cell Therapy Regenerative Medicine Revenue (US$ Million) Growth Rate (2021-2032)

Figure 19. Global Cell Therapy Regenerative Medicine Market Share by Players in 2025

Figure 20. Global Top Cell Therapy Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Therapy Regenerative Medicine as of 2025)

Figure 21. The Top 10 and 5 Players Market Share by Cell Therapy Regenerative Medicine Revenue in 2025

Figure 22. North America Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

Figure 23. North America Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

Figure 24. Europe Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

Figure 25. Europe Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

Figure 26. China Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

Figure 27. China Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

Figure 28. Japan Cell Therapy Regenerative Medicine Market Share by Type (2021-2026)

Figure 29. Japan Cell Therapy Regenerative Medicine Market Share by Application (2021-2026)

Figure 30. DePuy Synthes Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 31. Medtronic Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 32. ZimmerBiomet Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 33. Stryker Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 34. Allergan Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 35. MiMedx Group Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 36. Organogenesis Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 37. UniQure Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 38. FUJIFILM Cellular Dynamics Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 39. Osiris Therapeutics Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 40. Vcanbio Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 41. Gamida Cell Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 42. Golden Meditech Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 43. Cytori Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 44. Celgene Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 45. Vericel Corporation Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 46. Guanhao Biotech Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 47. Mesoblast Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 48. Stemcell Technologies Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 49. MD Anderson Revenue Growth Rate in Cell Therapy Regenerative Medicine Business (2021-2026)

Figure 50. Bottom-up and Top-down Approaches for This Report

Figure 51. Data Triangulation

Figure 52. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Cell Therapy Regenerative Medicine market size from 2026 to 2032? zhanKai

The annual compound growth rate of the global Cell Therapy Regenerative Medicine market is 17.3% 2026 to 2032.

What was the global market size of Cell Therapy Regenerative Medicine in 2032? shouQi

Which companies rank high in the global Cell Therapy Regenerative Medicine market? shouQi

What was the global market size of Cell Therapy Regenerative Medicine in 2026? shouQi

Which region is expected to have the highest market share? shouQi

Related Reports

Cell Therapy Regenerative Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ 27160 million in 2025 and is projected to reach US$ 81560 million, growing at a CAGR of 17.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 122
USD 3950.00
(Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2026
The global Cell Therapy Regenerative Medicine market was valued at US$ 27160 million in 2025 and is anticipated to reach US$ 81560 million by 2032, at a CAGR of 17.3% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 127
USD 2900.00
(Single User License)
Global Cell Therapy Regenerative Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Therapy Regenerative Medicine market is projected to grow from US$ 23561 million in 2024 to US$ 70595 million by 2031, at a CAGR of 17.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-24
Pages: 153
USD 4900.00
(Single User License)
Cell Therapy Regenerative Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ 23561 million in 2024 and is forecast to a readjusted size of US$ 70595 million by 2031 with a CAGR of 17.3% during the forecast period 2025-2031.
Published Date: 2025-10-24
Pages: 121
USD 3950.00
(Single User License)
Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Therapy Regenerative Medicine market size was US$ 23561 million in 2024 and is forecast to a readjusted size of US$ 70595 million by 2031 with a CAGR of 17.3% during the forecast period 2025-2031.
Published Date: 2025-10-24
Pages: 104
USD 4250.00
(Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2025
The global market for Cell Therapy Regenerative Medicine was valued at US$ 23561 million in the year 2024 and is projected to reach a revised size of US$ 70595 million by 2031, growing at a CAGR of 17.3% during the forecast period.
Published Date: 2025-10-24
Pages: 100
USD 2900.00
(Single User License)
Cell Therapy Regenerative Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 135
USD 3950.00
(Single User License)
Global Cell Therapy Regenerative Medicine Market Insights, Forecast to 2030
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
Published Date: 2024-04-26
Pages: 128
USD 4900.00
(Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2024
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
Published Date: 2024-01-18
Pages: 116
USD 2900.00
(Single User License)

Cell Therapy Regenerative Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ 27160 million in 2025 and is projected to reach US$ 81560 million, growing at a CAGR of 17.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 122
USD 3950.00 (Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2026
The global Cell Therapy Regenerative Medicine market was valued at US$ 27160 million in 2025 and is anticipated to reach US$ 81560 million by 2032, at a CAGR of 17.3% from 2026 to 2032.
Published: 2026-03-06
Pages: 127
USD 2900.00 (Single User License)
Global Cell Therapy Regenerative Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Therapy Regenerative Medicine market is projected to grow from US$ 23561 million in 2024 to US$ 70595 million by 2031, at a CAGR of 17.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-24
Pages: 153
USD 4900.00 (Single User License)
Cell Therapy Regenerative Medicine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ 23561 million in 2024 and is forecast to a readjusted size of US$ 70595 million by 2031 with a CAGR of 17.3% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 121
USD 3950.00 (Single User License)
Global Cell Therapy Regenerative Medicine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Therapy Regenerative Medicine market size was US$ 23561 million in 2024 and is forecast to a readjusted size of US$ 70595 million by 2031 with a CAGR of 17.3% during the forecast period 2025-2031.
Published: 2025-10-24
Pages: 104
USD 4250.00 (Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2025
The global market for Cell Therapy Regenerative Medicine was valued at US$ 23561 million in the year 2024 and is projected to reach a revised size of US$ 70595 million by 2031, growing at a CAGR of 17.3% during the forecast period.
Published: 2025-10-24
Pages: 100
USD 2900.00 (Single User License)
Cell Therapy Regenerative Medicine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Therapy Regenerative Medicine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 135
USD 3950.00 (Single User License)
Global Cell Therapy Regenerative Medicine Market Insights, Forecast to 2030
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
Published: 2024-04-26
Pages: 128
USD 4900.00 (Single User License)
Global Cell Therapy Regenerative Medicine Market Research Report 2024
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
Published: 2024-01-18
Pages: 116
USD 2900.00 (Single User License)